Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between the ages of 10 and 21 years old
- People who have been diagnosed with a specific type of pulmonary hypertension classified as either WHO Group 1 (PAH) or WHO Group 4 (CTEPH)
- People whose condition falls within WHO functional class I, II, or III (meaning symptoms range from none to moderate limitations on physical activity)
- People who have been on a stable treatment plan for their pulmonary hypertension for at least three months before joining, with only one diuretic (fluid-reducing medication) dose adjustment allowed in that time — adjustments to IV prostacyclin for managing side effects are also permitted
Who may not be able to join:
- People whose mobility is limited by being wheelchair-bound, bed-bound, reliant on a cane or walker, or who have another condition that significantly limits their physical activity (such as activity-limiting chest pain or joint disease)
- People who are pregnant
- People whose pulmonary hypertension has a cause other than idiopathic (unknown cause), heritable (genetic), or associated types (confirm with trial site)
- People with the most severe level of heart failure, classified as WHO functional class IV
- People who have needed more than two diuretic medication adjustments in the three months before joining
- People whose preferred form of physical activity cannot be tracked by a standard activity tracker — this includes swimming, yoga, ice skating, stair climbing machines, bicycling, or rollerblading
- People who are currently participating in another clinical research study involving an investigational treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Eric Austin, MD, Vanderbilt University Medical Center
Phone: (434) 851-3306
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in average daily step count from baseline to 12 weeks
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.